Cargando…
Prevalence of Polypoidal Choroidal Vasculopathy in Eyes with Neovascular Age-Related Macular Degeneration Resistant to Intravitreal Anti-VEGF Treatment
OBJECTIVES: To determine the prevalence of polypoidal choroidal vasculopathy (PCV) in intravitreal (IV) anti-vascular endothelial growth factor (anti-VEGF)-resistant neovascular age-related macular degeneration (nvAMD) cases. MATERIALS AND METHODS: Eyes that were diagnosed as having active and treat...
Autores principales: | Menteş, Jale, Esen Barış, Mine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631509/ https://www.ncbi.nlm.nih.gov/pubmed/36317811 http://dx.doi.org/10.4274/tjo.galenos.2021.16578 |
Ejemplares similares
-
Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy
por: Öztaş, Zafer, et al.
Publicado: (2016) -
Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
por: Matsumiya, Wataru, et al.
Publicado: (2011) -
Subgroups and Features of Poor Responders to Anti-Vascular Endothelial Growth Factor Treatment in Eyes with Neovascular Age-Related Macular Degeneration
por: Barış, Mine Esen, et al.
Publicado: (2020) -
Short-term outcomes of intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 choroidal neovascularization including polypoidal choroidal vasculopathy
por: Matsumoto, Hidetaka, et al.
Publicado: (2021) -
Multimodal Imaging Characteristics of Quiescent Type 1 Neovascularization in Best Vitelliform Macular Dystrophy
por: Menteş, Jale, et al.
Publicado: (2021)